NCT02959060 A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02957448 A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02846519 Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine Status COMPLETED Phase PHASE1
NCT02820935 Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02809768 Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02807116 Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02804399 A Study To Evaluate The Effect Of Rifampin On Pharmacokinetics Of PF-06463922 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02661893 A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922 Status COMPLETED Phase PHASE1
NCT02608034 A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State Status COMPLETED Phase PHASE1
NCT02576366 Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus Status COMPLETED Phase PHASE4
NCT02563327 Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis Status COMPLETED Phase PHASE3
NCT02547116 Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis Status WITHDRAWN Phase PHASE4
NCT02507167 Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8 Status COMPLETED Phase PHASE1
NCT02500667 A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02430545 Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics Status COMPLETED Phase PHASE1
NCT02372383 Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis Status COMPLETED Phase NA